---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-021660"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2026-01-26T23:59:59+00:00"
generated_at: "2026-05-16T07:57:53.776870+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Indivior completes U.S. Domestication; begins trading on Nasdaq as Delaware corp under INDV

## Summary
- Scheme of Arrangement effective Jan 23, 2026; Indivior U.S. becomes ultimate parent of Indivior U.K.
- Common stock starts trading on Nasdaq Jan 26, 2026 under ticker INDV; CUSIP 45579U109.
- New 2026 Omnibus Equity Plan authorizes 17.5M shares; non-employee director annual cash retainer $75k-$100k.
- Directors and executive officers of Indivior U.K. continue in same roles at Indivior U.S.
- Note Purchase Agreement amended to reflect Indivior U.S. as reporting entity; indemnification agreements adopted.

## SEC filing metadata
- accession: 0001193125-26-021660
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2026-01-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 3.03, 5.03, 5.01, 5.02, 8.01, 5.05, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000119312526021660/0001193125-26-021660-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000119312526021660/d87169d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-021660
- JSON: https://secwatch.observer/filing/0001193125-26-021660.json
- Plain text: https://secwatch.observer/filing/0001193125-26-021660.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.